Arrhythmias & electrophysiologyRandomised controlled trial
A randomized controlled implementation study integrating patient self-screening with a remote central monitoring system to screen community dwellers aged 75 years and older for atrial fibrillation
- Randomised controlled implementation study
- waitlist control
- May 2021 to June 2023
Authors' conclusion
Patient-led AF self-screening using single-lead ECG devices with a remote central monitoring system was feasible, acceptable, and effective in diagnosing AF among older people.
Study context
- Population
- Community-dwelling people aged ≥75 years
- Participants
- 200 people
- Comparison
- Electrocardiogram (ECG) self-screening virtual care system vs usual care
- Interventionn = 97
- Controln = 100reference
- Primary endpoint
- AF diagnosis rate
- Follow-up
- 6 months
Primary result
AF diagnosis
Odds ratio
5.6
95% CI 1.4–37.3
P = 0.03
Events by treatment group
Intervention vs Control
OR 5.6 (95% CI 1.4–37.3); P = 0.03
As reported in the abstract
Further findings
Satisfied with AF screening · 6 months
P < 0.001
- Atrial fibrillation (AF) cases diagnosed within 3 months (intervention)
- 80%
Monthly days with self-recorded ECG (of expected 20)
- Median days per month
- 20 (IQR 17-22)
Device usability
- Confident using the device
- 93%
- Easy to use
- 98%
- Screening efficient
- 96%
Original publication
A randomized controlled implementation study integrating patient self-screening with a remote central monitoring system to screen community dwellers aged 75 years and older for atrial fibrillation. Eur J Prev Cardiol. Published 25 September 2024. doi:10.1093/eurjpc/zwae312
Summarised from the published abstract; every number is checked against it